BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei XL, Qiu MZ, Chen WW, Jin Y, Ren C, Wang F, Luo HY, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH. The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer. J Transl Med 2013;11:249. [PMID: 24099678 DOI: 10.1186/1479-5876-11-249] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang T, Dong X, Zhou Y, Liu M, Hang J, Wu L. Development and validation of a radiomics nomogram to discriminate advanced pancreatic cancer with liver metastases or other metastatic patterns. Cancer Biomark 2021;32:541-50. [PMID: 34334383 DOI: 10.3233/CBM-210190] [Reference Citation Analysis]
2 Feng X, Lu H, Wei Y, Guan M, Wang J, Liu C, Shen T, Chen Q, Rao Q. Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer. Cancer Med 2021;10:8310-9. [PMID: 34672431 DOI: 10.1002/cam4.4358] [Reference Citation Analysis]
3 Fu Y, Yang X, Liang H, Wu X. Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection. Cancer Manag Res 2019;11:5091-100. [PMID: 31213920 DOI: 10.2147/CMAR.S198714] [Reference Citation Analysis]
4 Xiao W, Zhou Y, Yu P, Yang A, Zheng S, Tang H, Xie X. Prognostic value of chronic hepatitis B virus infection in patients with breast cancer in a hepatitis B virus endemic area. Ann Transl Med 2020;8:180. [PMID: 32309327 DOI: 10.21037/atm.2020.01.97] [Reference Citation Analysis]
5 Xiao Y, Lu J, Chang W, Chen Y, Li X, Li D, Xu C, Yang H. Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer. BMC Cancer 2019;19:785. [PMID: 31391026 DOI: 10.1186/s12885-019-6004-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Wu X, Li L, Li Y, Jiang M, Li K, Li Z, Zhang L. Prognostic value of serological markers of hepatitis B virus infection in squamous cell cervical cancer. J Cancer 2021;12:6620-8. [PMID: 34659552 DOI: 10.7150/jca.61249] [Reference Citation Analysis]
7 Chen S, Li X, Lv H, Wen X, Ding Q, Xue N, Su H, Chen H. Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection. Int J Biol Sci 2018;14:1813-21. [PMID: 30443185 DOI: 10.7150/ijbs.27260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Tao D, Zhang N, Huang Q, Ge C, Li Q, Li S, Weng K, Guo Q, Sui J, Wang C, Zhang X, Wang Y. Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma. Sci Rep 2020;10:21976. [PMID: 33319825 DOI: 10.1038/s41598-020-78892-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Deng QL, Dong S, Wang L, Zhang CY, Ying HF, Li ZS, Shen XH, Guo YB, Meng ZQ, Yu JM, Chen QW. Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma. Sci Rep 2017;7:11524. [PMID: 28912447 DOI: 10.1038/s41598-017-11227-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
10 Zhou J, Guo X, Huang P, Tan S, Lin R, Zhan H, Wu X, Li T, Huang M, Huang M. HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up. CMAR 2022;Volume 14:1581-94. [DOI: 10.2147/cmar.s350276] [Reference Citation Analysis]
11 Wei XL, Luo HY, Li CF, Jin Y, Zeng ZL, Ju HQ, Wu QN, Wang Y, Mao MJ, Liu WL, Jia WH, Zhang HZ, Li YH, Wang F, Xu RH. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers. Int J Cancer 2017;141:152-9. [PMID: 28369849 DOI: 10.1002/ijc.30719] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
12 Chen Y, Bai X, Zhang Q, Wen L, Su W, Fu Q, Sun X, Lou Y, Yang J, Zhang J, Chen Q, Wang J, Liang T. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway. Cancer Letters 2016;380:98-105. [DOI: 10.1016/j.canlet.2016.06.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
13 Monelli F, Besutti G, Djuric O, Bonvicini L, Farì R, Bonfatti S, Ligabue G, Bassi MC, Damato A, Bonelli C, Pinto C, Pattacini P, Giorgi Rossi P. The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:2246. [PMID: 34067076 DOI: 10.3390/cancers13092246] [Reference Citation Analysis]
14 Xu T, Huang Z, Deng Y, Wang S, Su B, Wei W, Wang D, Jiang J, Li A, Zhang G, Yang H, Claret FX, Hu W. Clinical implications of hepatitis B viral infection in Epstein-Barr virus-associated nasopharyngeal carcinoma. J Clin Virol 2015;64:64-71. [PMID: 25728081 DOI: 10.1016/j.jcv.2014.11.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
15 Chen Q, Ning Z, Wang L, Ying H, Dong S, Zhang C, Shen X, Guo Y, Chen H, Zhu X, Shen Y, Shi W, Hua Y, Wang K, Lin J, Xu L, Chen L, Feng L, Zhang X, Xie J, Sun B, Sun Y, Gu W, Kang M, Tang Z, Chen Z, Chen Z, Liu L, Yu J, Li Z, Meng Z. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study. Oncotarget 2016;7:85603-12. [PMID: 27811354 DOI: 10.18632/oncotarget.13000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Chen S, Lai Y, He Z, Li J, He X, Shen R, Ding Q, Chen H, Peng S, Liu W. Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection. J Transl Med 2018;16:116. [PMID: 29728103 DOI: 10.1186/s12967-018-1496-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
17 Huo T, Cao J, Tian Y, Shi X, Wu L, Zhang M, Wong LL, Zhao L. Effect of Concomitant Positive Hepatitis B Surface Antigen on the Risk of Liver Metastasis: A Retrospective Clinical Study of 4033 Consecutive Cases of Newly Diagnosed Colorectal Cancer. Clin Infect Dis 2018;66:1948-52. [PMID: 29293940 DOI: 10.1093/cid/cix1118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Li Z, Li S, Tao H, Zhan Y, Ni K, Gong J, Li G. Higher titer hepatitis B core antibody predicts a higher risk of liver metastases and worse survival in patients with colorectal cancer. World J Surg Oncol 2021;19:251. [PMID: 34446030 DOI: 10.1186/s12957-021-02369-1] [Reference Citation Analysis]
19 Zhang N, Tao D, Lei H, Shao Q, Liu Y, Long H, Zeng X. HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease. JIR 2022;Volume 15:2509-21. [DOI: 10.2147/jir.s355301] [Reference Citation Analysis]
20 Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 2019;18:97. [PMID: 31109338 DOI: 10.1186/s12943-019-1008-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 17.7] [Reference Citation Analysis]